Brevan Howard Capital Management’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-448,162
Closed -$811K 2439
2026
Q1
$811K Buy
+448,162
New +$775K 0.01% 1024
2025
Q3
Sell
-514,596
Closed -$499K 2185
2025
Q2
$499K Buy
+514,596
New +$427K ﹤0.01% 1354
2025
Q1
Sell
-13,982
Closed -$11.2K 1371
2024
Q4
$11.2K Buy
+13,982
New +$12.8K ﹤0.01% 993
2024
Q2
Sell
-69,268
Closed -$114K 1308
2024
Q1
$114K Buy
+69,268
New +$58.1K ﹤0.01% 881

Other funds holding OCGN

Brevan Howard Capital Management's OCGN Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 448,162 shares — an estimated $811K sold.

Brevan Howard Capital Management first reported a position in OCGN in Q1 2024 and held it in 4 quarters. The position peaked at $811K in Q1 2026. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 448,162 Ocugen shares in Q2 2026, an estimated $811K.
  • Brevan Howard Capital Management first reported a position in Ocugen in Q1 2024 and held it in 4 quarters.
  • Brevan Howard Capital Management's Ocugen position peaked at $811K in Q1 2026.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.